Advances in the prevention and treatment of breast cancer-related lymphedema.


Journal

Breast cancer research and treatment
ISSN: 1573-7217
Titre abrégé: Breast Cancer Res Treat
Pays: Netherlands
ID NLM: 8111104

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 30 01 2023
accepted: 06 04 2023
medline: 29 5 2023
pubmed: 27 4 2023
entrez: 27 4 2023
Statut: ppublish

Résumé

Breast cancer-related lymphedema (BCRL) represents a lifelong risk for breast cancer survivors and once acquired becomes a lifelong burden. This review summarizes current BCRL prevention and treatment strategies. Risk factors for BCRL have been extensively studied and their identification has affected breast cancer treatment practice, with sentinel lymph node removal now standard of care for patients with early stage breast cancer without sentinel lymph node metastases. Early surveillance and timely management aim to reduce BCRL incidence and progression, and are further facilitated by patient education, which many breast cancer survivors report not having adequately received. Surgical approaches to BCRL prevention include axillary reverse mapping, lymphatic microsurgical preventative healing (LYMPHA) and Simplified LYMPHA (SLYMPHA). Complete decongestive therapy (CDT) remains the standard of care for patients with BCRL. Among CDT components, facilitating manual lymphatic drainage (MLD) using indocyanine green fluorescence lymphography has been proposed. Intermittent pneumatic compression, nonpneumatic active compression devices, and low-level laser therapy appear promising in lymphedema management. Reconstructive microsurgical techniques such as lymphovenous anastomosis and vascular lymph node transfer are growing surgical considerations for patients as well as liposuction-based procedures for addressing fatty fibrosis formation from chronic lymphedema. Long-term self-management adherence remains problematic, and lack of diagnosis and measurement consensus precludes a comparison of outcomes. Currently, no pharmacological approaches have proven successful. Progress in prevention and treatment of BCRL continues, requiring advances in early diagnosis, patient education, expert consensus and novel treatments designed for lymphatic rehabilitation following insults.

Identifiants

pubmed: 37103598
doi: 10.1007/s10549-023-06947-7
pii: 10.1007/s10549-023-06947-7
pmc: PMC10224871
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-14

Informations de copyright

© 2023. The Author(s).

Références

Lymphology. 2011 Dec;44(4):168-77
pubmed: 22458118
Cancer Med. 2020 Jul;9(14):5164-5173
pubmed: 32483861
Springerplus. 2016 May 17;5:657
pubmed: 27330922
BMJ. 2010 Jan 12;340:b5396
pubmed: 20068255
Plast Reconstr Surg. 2013 Nov;132(5):1305-1314
pubmed: 24165613
Breast. 2019 Apr;44:15-23
pubmed: 30580170
Lymphat Res Biol. 2020 Aug;18(4):357-364
pubmed: 31944882
Lancet Oncol. 2013 May;14(6):500-15
pubmed: 23540561
Eur J Obstet Gynecol Reprod Biol. 2010 Mar;149(1):3-9
pubmed: 20018422
Ann Surg Oncol. 2011 Sep;18(9):2500-5
pubmed: 21369739
Lymphat Res Biol. 2021 Feb;19(1):56-65
pubmed: 33270517
J Cancer Surviv. 2023 Apr;17(2):384-398
pubmed: 36207626
Semin Oncol Nurs. 2013 Feb;29(1):20-7
pubmed: 23375063
Ann Surg. 2017 May;265(5):987-992
pubmed: 27163955
J Pers Med. 2015 May 20;5(2):153-64
pubmed: 26011383
J Vasc Surg Venous Lymphat Disord. 2022 May;10(3):786-795.e1
pubmed: 34508873
Ann Surg Oncol. 2021 Oct;28(10):5742-5751
pubmed: 34333706
Ann Surg Oncol. 2009 Mar;16(3):703-8
pubmed: 19139964
Breast J. 2018 Jan;24(1):62-65
pubmed: 29063664
N Engl J Med. 2018 Nov 15;379(20):1937-1944
pubmed: 30428297
Br J Surg. 2016 Feb;103(3):170-8
pubmed: 26661686
PM R. 2012 Aug;4(8):580-601
pubmed: 22920313
Lymphat Res Biol. 2014 Dec;12(4):289-94
pubmed: 25495384
Oncol Nurs Forum. 2013 Jul;40(4):383-93
pubmed: 23803270
Eur J Surg Oncol. 2022 Aug;48(8):1713-1717
pubmed: 35527056
Eur J Cancer Care (Engl). 2022 Nov;31(6):e13704
pubmed: 36113999
Ann Surg Oncol. 2014 Apr;21(4):1195-201
pubmed: 24558061
J Surg Res. 2011 Jan;165(1):82-90
pubmed: 20538293
Ann Surg Oncol. 2012 Aug;19(8):2580-9
pubmed: 22395997
Ann Surg Oncol. 2009 Jul;16(7):1959-72
pubmed: 19365624
J Plast Reconstr Aesthet Surg. 2016 Sep;69(9):1234-47
pubmed: 27425000
CA Cancer J Clin. 2009 Jan-Feb;59(1):8-24
pubmed: 19147865
Cancer. 2021 Jan 15;127(2):291-299
pubmed: 33079411
Gland Surg. 2018 Aug;7(4):379-403
pubmed: 30175055
Breast Cancer Res Treat. 2021 Jan;185(2):401-412
pubmed: 33006001
Am Soc Clin Oncol Educ Book. 2020 Mar;40:1-10
pubmed: 32315238
Cancer. 2012 Apr 15;118(8 Suppl):2312-24
pubmed: 22488705
J Natl Cancer Inst. 2001 Jan 17;93(2):96-111
pubmed: 11208879
Support Care Cancer. 2021 Feb;29(2):1081-1089
pubmed: 32613370
J Clin Oncol. 2020 Oct 10;38(29):3430-3438
pubmed: 32730184
Semin Plast Surg. 2018 Feb;32(1):42-47
pubmed: 29636653
Cancer. 2012 Apr 15;118(8 Suppl):2191-200
pubmed: 22488693
Clin Pharmacol Drug Dev. 2022 Feb;11(2):220-234
pubmed: 34779583
Int J Radiat Oncol Biol Phys. 2007 Mar 1;67(3):841-6
pubmed: 17175115
BMC Cancer. 2022 Aug 30;22(1):937
pubmed: 36042421
J Plast Reconstr Aesthet Surg. 2020 Sep;73(9):1612-1621
pubmed: 32513642
Lymphology. 2020;53(1):3-19
pubmed: 32521126
Lymphology. 2016 Jun;49(2):85-92
pubmed: 29906366
Breast Cancer Res Treat. 2002 Sep;75(1):51-64
pubmed: 12500934
BMC Cancer. 2017 Dec 7;17(1):833
pubmed: 29216916
J Clin Oncol. 2009 Jan 20;27(3):390-7
pubmed: 19064976
J Plast Reconstr Aesthet Surg. 2012 Jul;65(7):935-42
pubmed: 22373827
Front Oncol. 2018 Jun 12;8:197
pubmed: 29946531
Curr Breast Cancer Rep. 2013 Jun;5(2):134-144
pubmed: 26246870
Lymphology. 1998 Jun;31(2):74-86
pubmed: 9664272
Acta Oncol. 2000;39(3):399-405
pubmed: 10987238
Br J Surg. 2009 Aug;96(8):859-64
pubmed: 19591161
Ann Surg Oncol. 2017 Oct;24(10):2827-2835
pubmed: 28766218
Ann Surg Oncol. 2018 Oct;25(10):2948-2952
pubmed: 29987599
JAMA Oncol. 2022 Aug 1;8(8):1195-1200
pubmed: 35679026
Breast Cancer Res Treat. 2022 Aug;195(1):33-41
pubmed: 35816269
J Clin Oncol. 2008 Nov 10;26(32):5213-9
pubmed: 18838709
J Pain Symptom Manage. 2015 Dec;50(6):750-7
pubmed: 26303187
J Clin Oncol. 2013 Oct 20;31(30):3758-63
pubmed: 24043733
PLoS One. 2013 Apr 16;8(4):e60164
pubmed: 23613720
Semin Oncol Nurs. 2013 Feb;29(1):50-60
pubmed: 23375066
Breast Cancer Res Treat. 2007 Mar;101(3):285-90
pubmed: 16826318
World J Surg Oncol. 2013 Jan 24;11:15
pubmed: 23347817
Br J Cancer. 2018 Nov;119(10):1215-1222
pubmed: 30353049
J Surg Oncol. 2019 Aug;120(2):160-167
pubmed: 31144329
Ann Surg. 2016 Feb;263(2):399-405
pubmed: 25607768
Lymphology. 2012 Mar;45(1):13-25
pubmed: 22768469
Plast Reconstr Surg. 2012 Dec;130(6):1169-1178
pubmed: 22878475
Cochrane Database Syst Rev. 2015 May 21;(5):CD003475
pubmed: 25994425
Ann Surg Oncol. 2007 Jun;14(6):1890-5
pubmed: 17479341
Plast Reconstr Surg. 2019 Aug;144(2):486-496
pubmed: 31348365
Cancer. 2003 Sep 15;98(6):1114-22
pubmed: 12973834
Semin Plast Surg. 2018 Feb;32(1):22-27
pubmed: 29636650
Support Care Cancer. 2020 Feb;28(2):439-449
pubmed: 31656987
N Engl J Med. 2015 Jul 23;373(4):307-16
pubmed: 26200977
CA Cancer J Clin. 2015 Jan-Feb;65(1):55-81
pubmed: 25410402
Support Care Cancer. 2020 Aug;28(8):3593-3603
pubmed: 32415386
Eur J Vasc Endovasc Surg. 2013 May;45(5):516-20
pubmed: 23305787
Phys Ther. 2022 Oct 09;:
pubmed: 36209432
J Cancer Surviv. 2015 Jun;9(2):287-304
pubmed: 25432632
Nat Rev Dis Primers. 2019 Mar 28;5(1):22
pubmed: 30923312
Scand J Surg. 2003;92(4):287-95
pubmed: 14758919
J Am Coll Surg. 2021 Jun;232(6):982-994
pubmed: 33766726
West J Nurs Res. 2018 Dec;40(12):1800-1817
pubmed: 29191123
J Pers Med. 2021 May 12;11(5):
pubmed: 34065795
Acta Oncol. 2000;39(3):407-20
pubmed: 10987239
Lymphat Res Biol. 2022 Dec;20(6):618-628
pubmed: 35099283
Cancer. 2002 Dec 1;95(11):2260-7
pubmed: 12436430
J Clin Oncol. 2008 Dec 10;26(35):5689-96
pubmed: 19001331
Nurs Res. 2003 Nov-Dec;52(6):370-9
pubmed: 14639083
Psychooncology. 2017 Jun;26(6):849-855
pubmed: 27479170
Am J Clin Oncol. 2018 Feb;41(2):178-190
pubmed: 28009597
J Soc Integr Oncol. 2006 Winter;4(1):8-12
pubmed: 16737666
J Cancer Educ. 2017 Sep;32(3):629-633
pubmed: 27048148
Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):62-70
pubmed: 30165125
Biology (Basel). 2021 Sep 18;10(9):
pubmed: 34571811
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1263-70
pubmed: 26122375
Cancer. 2022 Sep 15;128(18):3284-3286
pubmed: 35797438
J Clin Oncol. 2017 Feb 10;35(5):561-564
pubmed: 27937089
BMC Cancer. 2019 Oct 22;19(1):985
pubmed: 31640623
J Vasc Surg Venous Lymphat Disord. 2022 Nov;10(6):1359-1366.e1
pubmed: 35952956
Sports Med. 2005;35(6):461-71
pubmed: 15974632
Lymphat Res Biol. 2017 Mar;15(1):87-98
pubmed: 28135120
PLoS One. 2016 Feb 26;11(2):e0150285
pubmed: 26919589
J Clin Oncol. 2022 Jun 20;40(18):2004-2012
pubmed: 35108031
JAMA Netw Open. 2020 Nov 2;3(11):e2024373
pubmed: 33175175
Cancer Nurs. 2012 Jan-Feb;35(1):E18-26
pubmed: 21558848
Breast Cancer Res Treat. 2018 Nov;172(1):83-91
pubmed: 30062571
Arch Surg. 2010 Nov;145(11):1055-63
pubmed: 21079093
Photomed Laser Surg. 2009 Oct;27(5):763-9
pubmed: 19878027
J Clin Oncol. 2020 Jul 10;38(20):2341-2350
pubmed: 32442064
Ann Surg Oncol. 2021 Dec;28(13):8624-8633
pubmed: 34117574
Breast Cancer Res Treat. 2016 Aug;159(1):1-14
pubmed: 27460637
Clin Breast Cancer. 2022 Jul;22(5):e664-e673
pubmed: 35370085
JCI Insight. 2018 Oct 18;3(20):
pubmed: 30333315
J Vasc Surg Venous Lymphat Disord. 2022 Jul;10(4):929-936
pubmed: 35364303
Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2734-46
pubmed: 20978176
Lasers Med Sci. 2014 May;29(3):1289-95
pubmed: 23192573
J Cancer Surviv. 2021 Apr;15(2):244-258
pubmed: 32803533
Breast. 2016 Aug;28:29-36
pubmed: 27183497
Ann Surg Oncol. 2020 Nov;27(12):4695-4701
pubmed: 32720042
Cancer. 2019 Mar 15;125(6):854-862
pubmed: 30521080
Cancer. 2022 Sep 15;128(18):3408-3415
pubmed: 35797441
Phys Ther. 2020 Jul 19;100(7):1163-1179
pubmed: 32589208
Breast Cancer (Dove Med Press). 2015 Oct 15;7:345-52
pubmed: 26527899
Lymphology. 2010 Sep;43(3):118-27
pubmed: 21226414
Patient Educ Couns. 2006 Apr;61(1):72-9
pubmed: 16533679
Support Care Cancer. 2019 Mar;27(3):991-1000
pubmed: 30105666
J Cancer Surviv. 2022 Aug 10;:
pubmed: 35947288
Phys Ther. 2012 Jan;92(1):152-63
pubmed: 21921254

Auteurs

Paula M C Donahue (PMC)

Physical Medicine and Rehabilitation, Vanderbilt University Medical Center, 2201 21St Children's Way, Suite 1218, Nashville, TN, 37212, USA. paula.m.donahue@vumc.org.
Dayani Center for Health and Wellness, Vanderbilt University Medical Center, Nashville, TN, USA. paula.m.donahue@vumc.org.

Adrien MacKenzie (A)

Osher Center for Integrative Health, Vanderbilt University Medical Center, Nashville, TN, USA.

Aleksandra Filipovic (A)

PureTech Health, London, UK.

Louise Koelmeyer (L)

Faculty of Medicine, Health, and Human Sciences, Australian Lymphoedema Education, Research, and Treatment (ALERT), Macquarie University, Sydney, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH